{"id":"https://openalex.org/W2048880420","doi":"https://doi.org/10.1111/cns.12158","title":"A 24\u2010Week, Randomized, Controlled Trial of Rivastigmine Patch 13.3 mg/24 h Versus 4.6 mg/24 h in Severe Alzheimer's Dementia","display_name":"A 24\u2010Week, Randomized, Controlled Trial of Rivastigmine Patch 13.3 mg/24 h Versus 4.6 mg/24 h in Severe Alzheimer's Dementia","alternate_titles":[],"publication_year":2013,"publication_date":"2013-08-07","ids":{"openalex":"https://openalex.org/W2048880420","doi":"https://doi.org/10.1111/cns.12158","mag":"2048880420","pmid":"https://pubmed.ncbi.nlm.nih.gov/23924050","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4233957"},"language":"en","primary_location":{"id":"doi:10.1111/cns.12158","doi":"https://doi.org/10.1111/cns.12158","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cns.12158","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cns.12158","source":{"id":"https://openalex.org/S84392608","display_name":"CNS Neuroscience & Therapeutics","issn_l":"1755-5930","issn":["1755-5930","1755-5949"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Neuroscience &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2048880420"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cns.12158","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071364728","display_name":"Martin Rhys Farlow","orcid":"https://orcid.org/0000-0001-7897-5471","observed_orcids":["https://orcid.org/0000-0001-7897-5471"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Martin R. Farlow","raw_affiliation_strings":["Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I4388446366","https://openalex.org/I4394709130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008190526","display_name":"George Thomas Grossberg","orcid":"https://orcid.org/0000-0002-1493-3931","observed_orcids":["https://orcid.org/0000-0002-1493-3931"]},"institutions":[{"id":"https://openalex.org/I47838141","display_name":"Saint Louis University","ror":"https://ror.org/01p7jjy08","country_code":"US","type":"education","lineage":["https://openalex.org/I47838141"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"George T. Grossberg","raw_affiliation_strings":["Department of Neurology and Psychiatry, St Louis University School of Medicine, St Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology and Psychiatry, St Louis University School of Medicine, St Louis, MO, USA","institution_ids":["https://openalex.org/I47838141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021670944","display_name":"Carl Sadowsky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I203088144","display_name":"Nova Southeastern University","ror":"https://ror.org/042bbge36","country_code":"US","type":"education","lineage":["https://openalex.org/I203088144"]},{"id":"https://openalex.org/I4210100958","display_name":"Palm Beach Neurology","ror":"https://ror.org/01bn2tj09","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100958"]},{"id":"https://openalex.org/I4210125763","display_name":"Premiere Research Institute","ror":"https://ror.org/02z2kxd64","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210125763"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carl H. Sadowsky","raw_affiliation_strings":["Division of Neurology, Nova Southeastern University, Fort Lauderdale, FL, USA","Premiere Research Institute, Palm Beach Neurology, West Palm Beach, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Neurology, Nova Southeastern University, Fort Lauderdale, FL, USA","institution_ids":["https://openalex.org/I203088144"]},{"raw_affiliation_string":"Premiere Research Institute, Palm Beach Neurology, West Palm Beach, FL, USA","institution_ids":["https://openalex.org/I4210100958","https://openalex.org/I4210125763"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101721800","display_name":"Xiangyi Meng","orcid":"https://orcid.org/0000-0002-2034-4551","observed_orcids":["https://orcid.org/0000-0002-2034-4551"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xiangyi Meng","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067438659","display_name":"Monique Somogyi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Monique Somogyi","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA","institution_ids":["https://openalex.org/I4210117619"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5071364728"],"corresponding_institution_ids":["https://openalex.org/I4388446366","https://openalex.org/I4394709130"],"apc_list":{"value":4140,"currency":"USD","value_usd":4140},"apc_paid":{"value":4140,"currency":"USD","value_usd":4140},"fwci":4.8266,"has_fulltext":true,"cited_by_count":86,"citation_normalized_percentile":{"value":0.95652839,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"19","issue":"10","first_page":"745","last_page":"752"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.5166000127792358,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.5166000127792358,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.29589998722076416,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.1703999936580658,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rivastigmine-patch","display_name":"rivastigmine patch","score":0.8859999775886536},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.8640000224113464},{"id":"https://openalex.org/keywords/advanced-dementia","display_name":"advanced dementia","score":0.9039999842643738},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.7239999771118164},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.8949999809265137},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.7210000157356262},{"id":"https://openalex.org/keywords/activities-of-daily-living","display_name":"activities of daily living","score":0.972000002861023},{"id":"https://openalex.org/keywords/functional-disability","display_name":"functional disability","score":0.47099998593330383},{"id":"https://openalex.org/keywords/neuropsychiatric-symptoms","display_name":"neuropsychiatric symptoms","score":0.8870000243186951},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8339999914169312},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.8199999928474426},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.31299999356269836},{"id":"https://openalex.org/keywords/action-study","display_name":"ACTION study","score":0.5559999942779541},{"id":"https://openalex.org/keywords/transdermal-drug-delivery","display_name":"transdermal drug delivery","score":0.6019999980926514},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.38100001215934753},{"id":"https://openalex.org/keywords/nursing-home-residents","display_name":"nursing home residents","score":0.46700000762939453},{"id":"https://openalex.org/keywords/caregiver-burden","display_name":"caregiver burden","score":0.40799999237060547},{"id":"https://openalex.org/keywords/caregiver-depression","display_name":"caregiver depression","score":0.8510000109672546},{"id":"https://openalex.org/keywords/caregiver-stress","display_name":"caregiver stress","score":0.4970000088214874}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.9000725746154785},{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.6693682074546814},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.647851288318634},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6315670013427734},{"id":"https://openalex.org/C2776000289","wikidata":"https://www.wikidata.org/wiki/Q5133761","display_name":"Clinical Global Impression","level":4,"score":0.6287436485290527},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5651096105575562},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5514211058616638},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.5432443022727966},{"id":"https://openalex.org/C2780084366","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demographics","level":2,"score":0.5177104473114014},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4488001763820648},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3201741576194763},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.12096402049064636},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.11812600493431091},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.0},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.0},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068836","descriptor_name":"Rivastigmine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D048448","descriptor_name":"Phenylcarbamates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D057968","descriptor_name":"Transdermal Patch","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1111/cns.12158","doi":"https://doi.org/10.1111/cns.12158","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cns.12158","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cns.12158","source":{"id":"https://openalex.org/S84392608","display_name":"CNS Neuroscience & Therapeutics","issn_l":"1755-5930","issn":["1755-5930","1755-5949"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Neuroscience &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4233957","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4233957/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Neurosci Ther","raw_type":"Text"},{"id":"pmid:23924050","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23924050","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS neuroscience & therapeutics","raw_type":"Comparative Study"},{"id":"pmh:oai:scholarworks.indianapolis.iu.edu:1805/9253","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/1805/9253","pdf_url":null,"source":{"id":"https://openalex.org/S4306400987","display_name":"IUScholarWorks (Indiana University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I592451","host_organization_name":"Indiana University","host_organization_lineage":["https://openalex.org/I592451"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Publisher","raw_type":"Article"},{"id":"pmh:oai:scholarworks.iupui.edu:1805/9253","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/1805/9253","pdf_url":null,"source":{"id":"https://openalex.org/S4306402593","display_name":"Purdue University Indianapolis (Indiana University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I592451","host_organization_name":"Indiana University","host_organization_lineage":["https://openalex.org/I592451"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Publisher","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1111/cns.12158","doi":"https://doi.org/10.1111/cns.12158","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cns.12158","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cns.12158","source":{"id":"https://openalex.org/S84392608","display_name":"CNS Neuroscience & Therapeutics","issn_l":"1755-5930","issn":["1755-5930","1755-5949"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Neuroscience &amp; Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308604","display_name":"Biogen","ror":"https://ror.org/02jqkb192"},{"id":"https://openalex.org/F4320310388","display_name":"Novartis Pharmaceuticals Corporation","ror":"https://ror.org/028fhxy95"},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320322546","display_name":"Shire","ror":"https://ror.org/02hb3t423"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320327918","display_name":"H. Lundbeck A/S","ror":"https://ror.org/0564cd633"},{"id":"https://openalex.org/F4320329568","display_name":"Grifols","ror":"https://ror.org/02ed64f32"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320332736","display_name":"Novartis Pharma","ror":"https://ror.org/0013shd50"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2048880420.pdf","grobid_xml":"https://content.openalex.org/works/W2048880420.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W163864813","https://openalex.org/W1164896577","https://openalex.org/W1751954123","https://openalex.org/W1847168837","https://openalex.org/W1963583371","https://openalex.org/W1996776294","https://openalex.org/W1996787470","https://openalex.org/W2022510347","https://openalex.org/W2037468903","https://openalex.org/W2045413014","https://openalex.org/W2052011640","https://openalex.org/W2052091788","https://openalex.org/W2064549315","https://openalex.org/W2067051260","https://openalex.org/W2067777747","https://openalex.org/W2070566742","https://openalex.org/W2072249708","https://openalex.org/W2099656611","https://openalex.org/W2111963393","https://openalex.org/W2112946832","https://openalex.org/W2118368258","https://openalex.org/W2137615734","https://openalex.org/W2141158065","https://openalex.org/W2156220037","https://openalex.org/W2159011576","https://openalex.org/W3022868799"],"related_works":["https://openalex.org/W2613858774","https://openalex.org/W7095539860","https://openalex.org/W2089558828","https://openalex.org/W2087653908","https://openalex.org/W2328239277","https://openalex.org/W2397860248","https://openalex.org/W1975507089","https://openalex.org/W2047901182","https://openalex.org/W2322345389","https://openalex.org/W2130649499"],"abstract_inverted_index":{"AIMS:":[0],"The":[1,128,216],"24-week,":[2],"prospective,":[3],"randomized,":[4],"double-blind":[5],"ACTION":[6],"study":[7],"investigated":[8],"the":[9,177,191],"efficacy,":[10],"safety,":[11],"and":[12,34,50,76,118,144,153,158,165,195,206,209,213,231],"tolerability":[13],"of":[14,54,69,190],"13.3":[15,87,115,129,192,217],"versus":[16],"4.6":[17,94,124,137,196,225],"mg/24":[18,88,95,116,125,130,138,193,197,218,226],"h":[19,89,96,117,126,131,139,194,198,219,227],"rivastigmine":[20],"patch":[21,132,140,199,220,228,240],"in":[22,236,246],"patients":[23,81],"with":[24,114,123],"severe":[25,247],"Alzheimer's":[26],"disease":[27],"(AD).":[28],"METHODS:":[29],"Patients":[30],"had":[31],"probable":[32],"AD":[33,51],"Mini-Mental":[35],"State":[36],"Examination":[37],"scores":[38],"\u22653-\u226412.":[39],"Primary":[40],"outcome":[41],"measures":[42],"were":[43,63,84,103,107,174],"as":[44,64,108],"follows:":[45,65,109],"Severe":[46],"Impairment":[47,58],"Battery":[48],"(SIB)":[49,143],"Cooperative":[52],"Study-Activities":[53],"Daily":[55],"Living":[56],"scale-Severe":[57],"Version":[59],"(ADCS-ADL-SIV).":[60],"Secondary":[61],"outcomes":[62],"ADCS-Clinical":[66],"Global":[67],"Impression":[68],"Change":[70],"(ADCS-CGIC),":[71],"12-item":[72],"Neuropsychiatric":[73],"Inventory":[74],"(NPI-12),":[75],"safety/tolerability.":[77],"RESULTS:":[78],"Of":[79],"1014":[80],"screened,":[82],"716":[83],"randomized":[85],"to":[86,136,224],"(N":[90,97,111,120],"=":[91,98,112,121,155,167,180,185],"356)":[92],"or":[93],"360)":[99],"patch.":[100,127],"Baseline":[101],"characteristics/demographics":[102],"comparable.":[104],"Completion":[105],"rates":[106],"64.3%":[110],"229)":[113],"65.0%":[119],"234)":[122],"was":[133],"significantly":[134],"superior":[135,222],"on":[141,176,229],"cognition":[142],"function":[145],"(ADCS-ADL-SIV)":[146],"at":[147],"Week":[148],"16":[149],"(P":[150,179,184],"<":[151,163],"0.0001":[152,164],"P":[154,162,166],"0.049,":[156],"respectively)":[157,208],"24":[159],"(primary":[160],"endpoint;":[161],"0.025).":[168],"Significant":[169],"between-group":[170],"differences":[171],"(Week":[172],"24)":[173],"observed":[175],"ADCS-CGIC":[178],"0.0023),":[181],"not":[182],"NPI-12":[183],"0.1437).":[186],"A":[187],"similar":[188],"proportion":[189],"groups":[200],"reported":[201],"adverse":[202],"events":[203],"(AEs;":[204],"74.6%":[205],"73.3%,":[207],"serious":[210],"AEs":[211],"(14.9%":[212],"13.6%).":[214],"CONCLUSIONS:":[215],"demonstrated":[221],"efficacy":[223],"SIB":[230],"ADCS-ADL-SIV,":[232],"without":[233],"marked":[234],"increase":[235],"AEs,":[237],"suggesting":[238],"higher-dose":[239],"has":[241],"a":[242],"favorable":[243],"benefit-to-risk":[244],"profile":[245],"AD.":[248]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2048880420","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
